Active substances
Aluminium hydroxide + Magnesium trisilicate
- SFDA 1
- US FDA 4
SFDA Saudi Arabia — SFDA human drug list
| Trade name | Strength | Form · route | Pack | Public price | Type | Company | Status |
|---|---|---|---|---|---|---|---|
| MALUGEL CHEWABLE TAB | 120, 250 mg | Chewable tablet · Oral use | 30 Blister | SAR 1.35 | NCE · OTC | Hikma Pharmaceuticals PLC | Withdrawn by MAH · Not Marketed |
US FDA United States — FDA approvals (Drugs@FDA)
| Product | Strength | Form · route | Applicant | Status | First approved |
|---|---|---|---|---|---|
| GAVISCON | 80MG;20MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**; 160MG;40MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | tablet, chewable · oral | CHATTEM SANOFI | Discontinued | 9 Dec 1983 |
| FOAMCOAT | 80MG;20MG | tablet, chewable · oral | GUARDIAN DRUG | Discontinued | 4 Sep 1987 |
| FOAMICON | 80MG;20MG | tablet, chewable · oral | NOVARTIS | Discontinued | 28 Jun 1989 |
| ALUMINUM HYDROXIDE AND MAGNESIUM TRISILICATE | 80MG;20MG | tablet, chewable · oral | PENNEX | Discontinued |
Components
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.